What we do.

Novabiosis, Inc. works directly with regulated US Organ Procurement Organizations (OPO’s) to facilitate the placement of whole non-transplantable organs and tissues for research.

Through our network of OPO’s, we can supply most non-transplantable organs and tissues for research, including: liver, lung, intestine, pancreas, kidney, spleen, brain, eye, birthing tissues, and full-thickness skin.

Another aspect of our business is the isolation and cryopreservation of high-quality human primary cells. With direct access to non-transplantable human organs through our OPO network; we can be very selective on the quality of organs we use for our primary cell isolations. Working directly with one of our OPO partners, with an isolation lab directly across the hall from their recovery suites, we can isolate cells immediately upon organ recovery, thus minimizing logistical challenges that can greatly impact cell isolation quality and yield.

Human primary cells offered by Novabiosis, Inc include cells from the: Liver, Lung, Kidney, and Intestine. Our key products include Hepatocytes, Kupffer, and Stellate cells from the Liver; Glomerular Endothelial Cells, Proximal Tubules, and Podocytes from the Kidney; Myofibroblasts from the Intestine; Fibroblasts and Epithelial cells from the Lung. In addition to our off-the-shelf products, Novabiosis offers unmatched custom isolation options through our internal experts or external partners like Zen-Bio.

In Q3 of 2023, Novabiosis will also offer animal primary hepatocytes, including dog, primate, and a variety of rodent strains.

Meet our team.

Matthew Shipton

President

Tim Smaldone

VP Organ and Tissue Operations

Ali Cuffy

Director Global Business Development

Nicoli Winders

Director of Human Biological Sample & Growth Strategies